The Irish Setter puppies are well-loved in the United States for their glowing red coats and lively personality, making them excellent companions for owners who can keep up with their energetic needs. However, like many purebred dogs, Irish Setters are prone to specific inherited conditions, including globoid cell leukodystrophy (GLD), commonly called Krabbe disease, a severe neurological disorder.
Originally bred as hunting dogs, Irish Setters are now cherished primarily as loyal family pets across America. Their high activity level requires ample daily exercise, and their gorgeous coats need consistent grooming to retain their shine and reduce indoor shedding.
Irish Setters usually have a lifespan of around 10 to 15 years. Still, a small number may develop hereditary illnesses such as GLD. This disease arises due to a lack of the enzyme galactocerebrosidase (GALC), crucial for breaking down harmful substances. Without sufficient GALC activity, toxic compounds like psychosine accumulate, damaging the nerve cells’ protective myelin sheath and causing progressive neurological decline.
Krabbe disease generally manifests in young puppies, typically between 1 to 3 months old. At first, affected puppies appear normal but soon start showing symptoms like muscle weakness, tremors, loss of coordination (ataxia), behavioral changes, seizures, reduced motor control, and sometimes blindness or deafness. Unfortunately, symptoms worsen as the disease progresses, and affected dogs often require humane euthanasia within their first year due to the condition’s incurability.
This condition is inherited following an autosomal recessive pattern, meaning a pup must inherit two defective copies of the GALC gene—one from each parent—to develop the disease. Dogs carrying one mutated gene (carriers) appear healthy but can pass the gene to their offspring. Understanding the genetic status of breeding dogs enables breeders to plan matings that avoid producing affected puppies.
Since Krabbe disease is fatal and has no treatment, prevention through diligent breeding practices is essential. DNA tests to identify the specific GALC mutation linked to the disease are readily accessible in the United States from reputable labs such as Wisdom Panel and others like Embark or Paw Print Genetics. These tests use samples like cheek swabs or blood draws, with results returned within about a week, classifying dogs as clear, carriers, or affected.
Testing procedure: A veterinarian typically collects a DNA sample via a cheek swab or blood test, which is then sent to an accredited laboratory. Testing allows breeders to know each dog's genetic status to make informed breeding decisions.
Reputable Irish Setter breeders in America routinely include GLD testing as part of their health protocols. Responsible breeders avoid mating two carriers or affected dogs. Instead, they pair carriers only with clear dogs to gradually phase out the mutation while preserving genetic diversity within the breed.
Awareness and early genetic screening supported by veterinary advice play a vital role in lowering GLD incidence, ensuring the breed’s health without compromising important bloodlines.
Prospective or current owners should inquire about health testing, including screening for Krabbe disease, when acquiring an Irish Setter from breeders or shelters. If you plan on breeding your dog, consult your veterinarian about genetic testing to understand your dog’s risk and responsibly guide breeding plans.
Being informed helps safeguard the breed and supports your dog's health and wellbeing.
For additional guidance or to locate reputable Irish Setter breeders who perform DNA testing, consult registered veterinary specialists and breed clubs such as the Irish Setter Club of America (ISCA).